Fox Run Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-5,470
Closed -$543K 587
2019
Q3
$543K Buy
+5,470
New +$543K 0.49% 31
2019
Q1
Sell
-3,379
Closed -$311K 768
2018
Q4
$311K Sell
3,379
-624
-16% -$63.1K 0.16% 252
2018
Q3
$441K Buy
4,003
+1,850
+86% +$193K 0.19% 225
2018
Q2
$201K Buy
+2,153
New +$185K 0.06% 581
2018
Q1
Sell
-4,818
Closed -$439K 1006
2017
Q4
$439K Buy
+4,818
New +$401K 0.13% 329
2017
Q1
Sell
-6,600
Closed -$364K 803
2016
Q4
$364K Buy
6,600
+2,300
+53% +$126K 0.19% 230
2016
Q3
$243K Buy
+4,300
New +$211K 0.14% 341

Other funds holding PRAH

Fox Run Management's PRAH Position: Q4 2019 in Review

Fox Run Management sold out of PRA Health Sciences, Inc. (PRAH) in Q4 2019, closing a stake of 5,470 shares — an estimated $543K sold.

Fox Run Management first reported a position in PRAH in Q3 2016 and held it in 7 quarters. The position peaked at $543K in Q3 2019. 345 funds tracked by Wall St. Rank hold PRAH as of Q4 2019.

  • Fox Run Management reported no remaining PRA Health Sciences, Inc. position as of Q4 2019 after selling out during the quarter.
  • Fox Run Management sold 5,470 PRA Health Sciences, Inc. shares in Q4 2019, an estimated $543K.
  • Fox Run Management first reported a position in PRA Health Sciences, Inc. in Q3 2016 and held it in 7 quarters.
  • Fox Run Management's PRA Health Sciences, Inc. position peaked at $543K in Q3 2019.
  • 345 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2019.

Based on Fox Run Management's 13F filing for Q4 2019, filed 14 Feb 2020.